The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I-b study of isatuximab + carfilzomib in relapsed and refractory multiple myeloma (RRMM).
 
Ajai Chari
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Array Biopharma; Bayer; Celgene; Janssen Oncology; Millennium; Novartis; Seagen
Research Funding - Acetylon Pharmaceuticals (Inst); Array BioPharma; Biotest (Inst); Bristol-Myers Squibb (Inst); Celgene; Janssen; Millennium; Novartis; Onyx; Pharmacyclics
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Novartis; Takeda
 
Joshua Ryan Richter
Consulting or Advisory Role - Amgen; Celgene; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Takeda
 
Nina Shah
Stock and Other Ownership Interests - Indapta Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Indapta Therapeutics; Sanofi; Takeda; TeneoBio
Research Funding - Bluebird Bio; Celgene; Janssen
 
Sandy Wai Kuan Wong
No Relationships to Disclose
 
Sundar Jagannath
No Relationships to Disclose
 
Hearn J. Cho
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Janssen Research & Development
Research Funding - Agenus; Bristol-Myers Squibb; Janssen Research & Development
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
 
Noa Biran
Consulting or Advisory Role - Amgen; Celgene; Takeda
Speakers' Bureau - Amgen; Celgene; Sanofi; Takeda
Research Funding - Merck
 
Jeffrey Wolf
No Relationships to Disclose
 
Samir S. Parekh
No Relationships to Disclose
 
Pamela N. Munster
Stock and Other Ownership Interests - OncoSec (I)
Honoraria - Amgen (I); Prometheus (I); Threshold Pharmaceuticals
Consulting or Advisory Role - HUYA Bioscience International
Research Funding - Andes Biotechnologies (Inst); Biomarin (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Intellikine (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); OncoMed (Inst); Onconova Therapeutics (Inst); oncosec (Inst); Pfizer (Inst); Piramal Life Science (Inst); Plexxikon (Inst); Sanofi (Inst)
 
Deepu Madduri
Employment - Roivant (I)
Leadership - Roivant (I)
Stock and Other Ownership Interests - Roivant (I)
Honoraria - Abbvie
Consulting or Advisory Role - Abbvie
Speakers' Bureau - Baxalta/Shire
Patents, Royalties, Other Intellectual Property - Roviant Sciences (I)
 
Frank Campana
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Thomas G. Martin
Consulting or Advisory Role - TeneoBio
Research Funding - AMGEN (Inst); Genentech/Roche (Inst); Sanofi (Inst)